| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.04B | 57.97B | 48.13B | 40.64B | 34.81B | 27.95B |
| Gross Profit | 9.43B | 11.10B | 9.03B | 7.78B | 7.01B | 5.81B |
| EBITDA | 4.28B | 5.45B | 3.91B | 3.07B | 2.57B | 2.02B |
| Net Income | 2.01B | 2.60B | 1.81B | 1.51B | 1.27B | 1.12B |
Balance Sheet | ||||||
| Total Assets | 30.73B | 36.62B | 31.60B | 25.54B | 21.23B | 18.14B |
| Cash, Cash Equivalents and Short-Term Investments | 4.60B | 9.14B | 4.68B | 4.06B | 3.49B | 3.51B |
| Total Debt | 8.82B | 10.20B | 9.47B | 5.93B | 3.98B | 2.75B |
| Total Liabilities | 17.14B | 20.50B | 18.09B | 13.22B | 10.36B | 8.28B |
| Stockholders Equity | 13.58B | 16.11B | 13.51B | 12.31B | 10.87B | 9.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.38B | -1.20B | 163.47M | 328.25M | 874.93M |
| Operating Cash Flow | 0.00 | 4.99B | 2.37B | 3.03B | 665.05M | 1.48B |
| Investing Cash Flow | 0.00 | -668.90M | -4.53B | -3.27B | -1.34B | -1.00B |
| Financing Cash Flow | 0.00 | 172.04M | 2.75B | 818.57M | 714.62M | -107.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥85.26B | 11.81 | ― | 3.48% | 1.42% | 32.92% | |
74 Outperform | ¥15.93B | 10.60 | ― | 3.37% | 2.44% | 3.81% | |
72 Outperform | ¥26.07B | 9.39 | ― | 2.33% | 20.46% | 45.70% | |
70 Outperform | ¥146.10B | 10.77 | ― | 3.65% | 3.06% | 1.48% | |
70 Outperform | ¥14.36B | 9.45 | ― | 3.85% | 8.49% | 32.73% | |
65 Neutral | ¥13.57B | 9.42 | ― | 3.04% | 3.34% | 11.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |